Mesoblast Investigational Site 13027 - Emory University School of Medicine — Atlanta, Georgia

Mesoblast Investigational Site 13027 - Emory University School of Medicine is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mesoblast Investigational Site 13027 - Emory University School of Medicine has participated in 1 clinical trials.

Therapeutic areas: Chronic Heart Failure.

Sponsors: Mesoblast, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mesoblast Investigational Site 13027 - Emory University School of Medicine?

Mesoblast Investigational Site 13027 - Emory University School of Medicine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mesoblast Investigational Site 13027 - Emory University School of Medicine conducted?

Mesoblast Investigational Site 13027 - Emory University School of Medicine has 1 clinical trials on record. Their work covers Chronic Heart Failure.

Is Mesoblast Investigational Site 13027 - Emory University School of Medicine accredited by Crixeo Health?

Mesoblast Investigational Site 13027 - Emory University School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mesoblast Investigational Site 13027 - Emory University School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.